ArticleMetabolic brain disease2024
Effects of ginger root extract on cognitive impairment and the Nrf2/GPX4/SLC7A11 signaling pathway in aluminum-exposed rats.
Article in Metabolic brain disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Targeting ferroptosis with culinary spices: a dietary strategy for neuroprotection via the Nrf2/GPX4 axis.Frontiers in nutrition · 2026Review
- Oxidative cell death in the central nervous system: mechanisms and therapeutic strategies.Frontiers in cell and developmental biology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aluminum exposure has been widely demonstrated to cause cognitive impairment and neuronal damage, which are significant factors in many neurodegenerative diseases. Ginger root extract (GRE) has attracted researchers' attention in recent years due to its antioxidant and neuroprotective properties, as a potential therapeutic intervention to mitigate aluminum-induced neural damage.To evaluate the effects of GRE on cognitive impairment and the expression of Nrf2, GPX4, and SLC7A11 in aluminum (Al)-exposed rats. In this study, a total of 60 male Sprague-Dawley (SD) rats were randomly assigned to 6 groups: Control, Al exposure (Al), Clinical Drug, low-dose GRE (Al + L-GRE), medium-dose GRE (Al + M-GRE), and high-dose GRE (Al + H-GRE). All groups, except Control, received 10 mg/ml AlCl₃ in drinking water for three months. Post-exposure treatments included saline for Control and Al groups, 0.5 mg/kg donepezil hydrochloride for the Clinical Drug group, and 100, 200, and 400 mg/kg GRE for the respective GRE groups. Treatments were administered once daily, five days a week, for a duration of one month. Cognitive and spatial abilities were assessed using the Morris water maze and Y-maze tests. Neuronal damage and mitochondrial structure in the hippocampus were evaluated via Nissl staining and transmission electron microscopy. Serum levels of SOD, GSH, MDA, and Fe²⁺ were measured, and Nrf2/GPX4/SLC7A11 mRNA and protein levels in hippocampal tissues were analyzed using real-time PCR and Western blotting. The Al group demonstrated compromised cognitive function, diminished neuronal integrity, disrupted mitochondrial structure, and an imbalance in serum antioxidant levels compared to the Control group.GRE treatment appeared to have a positive effect on cognitive function, potentially contributing to the maintenance of neuronal integrity, possibly aiding in the preservation of mitochondrial structure, and potentially assisting in the regulation of antioxidant levels. Notably, the Al + M-GRE and Al + H-GRE groups demonstrated encouraging enhancements in escape latency, platform crossings, novel arm entries, and time spent in the novel arm. Additionally, these groups showed elevated levels of SOD and GSH, reduced levels of MDA and Fe²⁺, and increased expression of Nrf2, GPX4, and SLC7A11, suggesting a potential beneficial impact of GRE treatment.GRE mitigated cognitive impairment in Al-exposed rats, likely through the Nrf2/GPX4/SLC7A11 signaling pathway, demonstrating its potential neuroprotective effects.
Indexed as
Identifiers
39661217What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.